October 7th 2026
As autoimmune thyroid testing grows, QC manufacturers face an increasing challenge to secure anti-TPO materials that combine reliable performance with consistent, long-term supply.
Native anti-TPO serum and plasma provide excellent clinical relevance, but high-titre material can be difficult to source. Engineered Human Fc anti-TPO antibodies offer an alternative route to greater consistency and scalable supply.
Sorry, no products matched your criteria. Try a different search
